Difficult to treat infections and antimicrobians use

Oscar Murillo Rubio

PRINCIPAL INVESTIGATORS
  • María Del Carmen Cabellos Mínguez
  • Arkaitz Imaz Vacas
  • Mireia Puig Asensio
  • Evelyn Shaw Perujo
CLINICAL RESEARCHERS
  • Eva Benavent Palomares
  • Francisco Javier Cabo Cabo
  • Raül Rigo Bonnin
  • María Saumoy Linares
  • Laura Soldevila Boixader
  • Fe Tubau Quintano
POSTDOCTORAL RESEARCHERS
  • Maria Cristina El Haj Hidalgo
PREDOCTORAL RESEARCHERS
  • Judith Poblet Florentin
Translational Medicine
Infectious disease and transplantation

Scientific production

37

PAPERS

Average IF: 4,88

10

LED PAPERS

Average IF: 4,22

7 PUBLICATIONS IN FIRST DECILE

27 PUBLICATIONS IN FIRST QUARTILE

25 PUBLICATIONS IN OPEN ACCESS

Selected publications

  • Bailon,L;Molto,J;Curran,A;Cadiñanos,J;de Quiros,JCLB;de los Santos,I;Ambrosioni,J et al, Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial, Nat. Commun., 2025;16(1):2146-2146, doi:10.1038/s41467-025-57284-w
  • Martin Carmona,J;Corma Gomez,A;Moyano,JM;Tellez,F;Arenga Barrios,D;Serrano Fuentes,M;Vazquez,ACM et al, Impact of HIV infection on the dynamics of liver stiffness in patients with hepatitis C virus chronic infection after sustained virological response, EClinicalMedicine, 2025;83103227-103227, doi:10.1016/j.eclinm.2025.103227
  • Jimenez Morales,A;Solis Garrido,A;Toirac,B;Mediero,A;Costa,B;Mulero,F;Murillo,O et al, Bilayer sol-gel system for local prevention in prosthetic joint infections and osteointegration improvement, Commun. Mater., 2025;6(1):doi:10.1038/s43246-025-00790-7
  • Ulsamer,A;Betbesé,AJ;Campos Gómez,A;Centelles,J;Domínguez,E;Iglesias Serret,D;Lorente Olazábal,JV et al, Buffers in intravenous solutions: is the source of bicarbonate a source of confusion?, Crit. Care, 2025;29(1):539-539, doi:10.1186/s13054-025-05780-2
  • Gómez Junyent,J;Lora Tamayo,J;Sorlí,L;Murillo,O, Challenges and strategies in the treatment of periprosthetic joint infection caused by multidrug-resistant Gram-negative bacteria: a narrative review., Clin Microbiol Infect, 2025;31(9):1458-1466, doi:10.1016/j.cmi.2025.06.015

Research highlights

PROJECTS

1 Granted competitive project
8 Ongoing competitive projects

4 Started clinical trials
10 Ongoing clinical trials
1 Ongoing non competitive project

PUBLISHED WORKS

2 Theses

NETWORKS

CIBERINFEC
AGAUR-SGR GRC
CSUR

Selected projects

  • PI23/01031. Problemática de la infección asociada a biofilms de P. aeruginosa XDR/DTR: evaluación de alternativas terapéuticas y de su impacto en la estructura del biofilm y el resistoma. Instituto de Salud Carlos III (ISCIII). Budget: 141.250€. 2024-2026. PI: OSCAR MURILLO RUBIO.
  • PI21/00862. Vigilancia semi-automatizada de las infecciones quirúrgicas: el avance hacia una estrategia mejorada para la prevención y control de las infecciones relacionadas con la atención sanitaria. Instituto de Salud Carlos III (ISCIII). Budget: 120.395€. 2022-2026. PI: MIREIA PUIG ASENSIO.
  • PI21/01302. Infecciones de transmisión sexual por Mycoplasma genitalium: historia natural, persistencia, factores relacionados e implicaciones clínicas.. Instituto de Salud Carlos III (ISCIII). Budget: 91.960€. 2022-2026. PI: ARKAITZ IMAZ VACAS.
  • Efficacy of Delafloxacin alone and in combination with rifampicin against in vitro foreign-body infection caused by methicillin-resistant Staphylococcus aureus: a pharmacodynamic Study. Laboratorios Menarini, S.A.. Budget: 72.876,25€. 2024-2026. PI: OSCAR MURILLO RUBIO.
  • INT24/00075. CONTRATO INTENSIFICACIÓN ISCIII. Instituto de Salud Carlos III (ISCIII). Budget: 60.000€. 2025-2026. PI: OSCAR MURILLO RUBIO.